Product Description: Remdesivir-d5 is a deuterium labeled Remdesivir. Remdesivir (GS-5734) is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of 2019-nCoV (COVID-19) infection in vitro[1][2].
Applications: COVID-19-anti-virus
Formula: C27H30D5N6O8P
References: [1]Wang M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271./[2]Agostini ML, et al. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. MBio. 2018 Mar 6;9(2). pii: e00221-18.
Molecular Weight: 607.61
Compound Purity: 99.86
Research Area: Infection
Solubility: 10 mM in DMSO/DMSO : 100mg/mL (ultrasonic)
Target: DNA/RNA Synthesis;SARS-CoV
English
Deutsch
